Company Overview and News

 
News LIVE: Islamabad HC suspends ex-Pakistan#39;s PM Nawaz Sharif, daughter#39;s jail term

2018-09-19 moneycontrol
JUST IN | Islamabad High Court has suspended jail terms of former Pak PM Nawaz Sharif, his daughter Maryam Nawaz and son-in-law Captain (retd) Muhammad Safdar in Avenfield case, reports Geo News.
532343 532693 TVSMOTOR PUNJLLOYD

 
News LIVE: Cabinet approves ordinance on Triple Talaq

2018-09-19 moneycontrol
JUST IN | Delhi High Court dismisses a public interest litigation (PIL) seeking clarity on formula by OMCs to fix fuel prices, reports CNBC TV18.
532343 532693 TVSMOTOR PUNJLLOYD

 
Punj Lloyd Limited - Book Closure

2018-09-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532693 PUNJLLOYD

 
Punj Lloyd Limited - Reply to Clarification Sought

2018-08-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532693 PUNJLLOYD

 
Punj Lloyd down 3% on resignation of directors

2018-08-28 moneycontrol
Shares of Punj Lloyd declined 3 percent intraday Tuesday on the back of resignation of company's director.
532693 PUNJLLOYD

 
Punj Lloyd Limited - Resignation

2018-08-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532693 PUNJLLOYD

 
As RBI#39;s Aug 27 deadline looms, over 60 large stressed loans worth over Rs 3 lakh cr stare at insolvency process

2018-08-25 moneycontrol
As the Reserve Bank of India’s (RBI) deadline to resolve large stressed assets ends on Monday, as many as 60 stressed loan accounts worth over Rs 3 lakh crore stare at insolvency proceedings.
MBECL 532718 GAYAPROJ PRATIBHA PUNJLLOYD 532629 532715 PATELENG 532767 532775 GTLINFRA GITANJALI GTJLY 532693 531120 GAMMONIND 509550 SBAZ

 
Punj Lloyd Limited - Clarification

2018-08-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532693 PUNJLLOYD

 
Punj Lloyd Limited - Financial Result Updates

2018-08-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532693 PUNJLLOYD

 
1,066 firms to declare results on Tuesday

2018-08-13 thehindubusinessline
Among the 1,066 companies that will declare their April-June results on Tuesday are Allahabad Bank, Aster DM, Bharat Dynamics, Cox & Kings, DB Realty, Dilip Buildcon, Essar Shipping, Fortis Health, GMR Infra, Grasim, GVK Power, HDIL, IDBI Bank, Ind-Swift, IB Real Estate, IVRCL, Karuturi, MTNL, MMTC, NLC India, Noida Toll, Punj Lloyd, Puravankara, Rain Industries, Simplex Infra, Steel Strips Wheels, Sun Pharma, Suven Life, Uniply, Valecha, Voltamp and WS Ind.
RAIN ESSARSHPNG 513262 532693 500116 533704 PUNJLLOYD IDBI 500339 532480 ALBK SSWL

 
Punj Lloyd Limited - Shareholders meeting

2018-07-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532693 PUNJLLOYD

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...